Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
10.63
-0.49 (-4.41%)
At close: Dec 24, 2024, 4:00 PM
11.16
+0.53 (4.99%)
After-hours: Dec 24, 2024, 4:17 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $1.72 billion as of December 26, 2024. Its market cap has decreased by -13.29% in one year.
Market Cap
1.72B
Enterprise Value
1.38B
1-Year Change
-13.29%
Ranking
Category
Stock Price
$10.63
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $1.72B, a decrease of -33.52%. That is a compound annual growth rate of -27.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 1.72B | -34.04% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.94B |
| CG Oncology | 1.90B |
| Disc Medicine | 1.90B |
| Amphastar Pharmaceuticals | 1.88B |
| ImmunityBio | 1.86B |
| 10x Genomics | 1.78B |
| Galapagos NV | 1.76B |
| Arcutis Biotherapeutics | 1.75B |